AMS.L Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:35):

Stats
Today's Volume	203 266
Average Volume	622 690
Market Cap	403.09M
EPS	£0 ( 2024-03-16 )
Last Dividend	£1.510 ( 2023-05-18 )
Next Dividend	£0 ( N/A )
P/E	26.54
ATR14	£0.382 (0.20%)

Volume Correlation

Long: 0.05 (neutral)

Short: 0.48 (neutral)

Signal:(51.095) Neutral

Advanced Medical Correlation

10 Most Positive Correlations
EJFI.L	0.861
PSON.L	0.855
VSL.L	0.845
ALL.L	0.841
NAIT.L	0.84
WIN.L	0.837
MIG.L	0.836
BEZ.L	0.836
LXI.L	0.834
DHSD.L	0.833

10 Most Negative Correlations
TFG.L	-0.877
UD04.L	-0.855
OCTP.L	-0.851
7DIG.L	-0.836
UAI.L	-0.835
FAN.L	-0.818
CALL.L	-0.805

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Advanced Medical Correlation - Currency/Commodity

0.25
( neutral )

0.33
( neutral )

-0.04
( neutral )

0.11
( neutral )

-0.44
( neutral )

0.05
( neutral )

Advanced Medical Financials

Annual	2023
Revenue:	£126.21M
Gross Profit:	£63.73M (50.49 %)
EPS:	£0.0736

FY	2023
Revenue:	£126.21M
Gross Profit:	£63.73M (50.49 %)
EPS:	£0.0736

FY	2022
Revenue:	£124.33M
Gross Profit:	£68.62M (55.19 %)
EPS:	£0.0942

FY	2021
Revenue:	£108.60M
Gross Profit:	£61.07M (56.23 %)
EPS:	£0.0813

Financial Reports:

No articles found.

Advanced Medical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0.640 (N/A)	£0 (N/A)	£0 (N/A)	£1.510 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Advanced Medical Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.65 - Stable (6.91%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£0.380	2011-05-11
Last Dividend	£1.510	2023-05-18
Next Dividend	£0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	26	--
Total Paid Out	£14.14	--
Avg. Dividend % Per Year	0.41%	--
Score	3.95	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.65
Div. Directional Score	8.41	--

Next Divdend (Est)
(2024-09-23)

£0 Estimate 3.72 %

Dividend Stability

0.30 Very Poor

Dividend Score

3.95

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2011	£0.525	0.72%
2012	£0.475	0.51%
2013	£0.540	0.85%
2014	£0.630	0.57%
2015	£0.730	0.58%
2016	£0.850	0.48%
2017	£0.970	0.44%
2018	£1.170	0.38%
2019	£1.400	0.51%
2020	£1.550	0.53%
2021	£1.780	0.73%
2022	£2.01	0.61%
2023	£1.510	0.57%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
PNL.L	Dividend Knight	2023-08-24	Quarterly	41	0.75%
FSFL.L	Dividend Knight	2023-07-20	Quarterly	11	3.85%
AERI.L	Dividend Knight	2023-08-17	Quarterly	6	2.80%
THRG.L	Dividend Knight	2023-08-03	Semi-Annually	52	1.02%
LMP.L	Dividend Knight	2023-08-31	Quarterly	17	2.52%
CMCL.L	Dividend Knight	2023-07-13	Quarterly	12	3.19%
RIII.L	Dividend Knight	2023-08-24	Semi-Annually	44	1.13%
HCFT.L	Dividend Knight	2023-09-21	Semi-Annually	32	4.67%
ASY.L	Dividend Knight	2023-05-25	Semi-Annually	32	2.95%
ULVR.L	Dividend King	2023-08-03	Quarterly	33	2.11%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.126	1.500	7.48	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0549	1.200	8.17	9.80	[0 - 0.3]
returnOnEquityTTM	0.0653	1.500	-0.386	-0.579	[0.1 - 1]
payoutRatioTTM	0.301	-1.000	6.99	-6.99	[0 - 1]
currentRatioTTM	5.67	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	4.00	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.79	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.00403	-1.500	9.93	-10.00	[0 - 0.6]
interestCoverageTTM	11.88	1.000	6.71	6.71	[3 - 30]
operatingCashFlowPerShareTTM	0.0666	2.00	9.98	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0212	2.00	9.99	10.00	[0 - 20]
debtEquityRatioTTM	0.00477	-1.500	9.98	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.505	1.000	4.92	4.92	[0.2 - 0.8]
operatingProfitMarginTTM	0.142	1.000	9.16	9.16	[0.1 - 0.6]
cashFlowToDebtRatioTTM	12.42	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.436	0.800	-0.424	-0.339	[0.5 - 2]
Total Score				12.17

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	25.48	1.000	7.53	0	[1 - 100]
returnOnEquityTTM	0.0653	2.50	-0.248	-0.579	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0212	2.00	9.99	10.00	[0 - 30]
dividendYielPercentageTTM	1.184	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0666	2.00	9.98	10.00	[0 - 30]
payoutRatioTTM	0.301	1.500	6.99	-6.99	[0 - 1]
pegRatioTTM	-143.55	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.115	1.000	9.64	0	[0.1 - 0.5]
Total Score				4.65

Advanced Medical

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and laparoscopic device used to fix hernia meshes placed inside the body under the LiquiBand Fix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products under the ActivHeal brand. Advanced Medical Solutions Group plc was incorporated in 1991 and is headquartered in Winsford, the United Kingdom.